Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.

Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T; IPMSSG.

Neurology. 2019 May 28;92(22):e2538-e2549. doi: 10.1212/WNL.0000000000007572. Epub 2019 May 1. Erratum in: Neurology. 2019 Oct 1;93(14):647.

2.

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome.

Makhani N, Lebrun C, Siva A, Narula S, Wassmer E, Brassat D, Brenton JN, Cabre P, Carra Dallière C, de Seze J, Durand Dubief F, Inglese M, Langille M, Mathey G, Neuteboom RF, Pelletier J, Pohl D, Reich DS, Ignacio Rojas J, Shabanova V, Shapiro ED, Stone RT, Tenembaum S, Tintoré M, Uygunoglu U, Vargas W, Venkateswaren S, Vermersch P, Kantarci O, Okuda DT, Pelletier D; Observatoire Francophone de la Sclérose en Plaques (OFSEP), Société Francophone de la Sclérose en Plaques (SFSEP), the Radiologically Isolated Syndrome Consortium (RISC) and the Pediatric Radiologically Isolated Syndrome Consortium (PARIS).

Mult Scler J Exp Transl Clin. 2019 Mar 20;5(1):2055217319836664. doi: 10.1177/2055217319836664. eCollection 2019 Jan-Mar.

3.

Pediatric Multiple Sclerosis: Distinguishing Clinical and MR Imaging Features.

Tenembaum SN.

Neuroimaging Clin N Am. 2017 May;27(2):229-250. doi: 10.1016/j.nic.2016.12.007. Review.

PMID:
28391783
4.

Pediatric multiple sclerosis: Conventional first-line treatment and general management.

Ghezzi A, Amato MP, Makhani N, Shreiner T, Gärtner J, Tenembaum S.

Neurology. 2016 Aug 30;87(9 Suppl 2):S97-S102. doi: 10.1212/WNL.0000000000002823. Review. Erratum in: Neurology. 2016 Nov 8;87(19):2068.

PMID:
27572869
5.

Neuromyelitis optica spectrum disorders in children and adolescents.

Tenembaum S, Chitnis T, Nakashima I, Collongues N, McKeon A, Levy M, Rostasy K.

Neurology. 2016 Aug 30;87(9 Suppl 2):S59-66. doi: 10.1212/WNL.0000000000002824. Review.

PMID:
27572863
6.

Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome.

Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL.

Neurology. 2016 Aug 30;87(9 Suppl 2):S38-45. doi: 10.1212/WNL.0000000000002825. Review.

PMID:
27572859
7.

International Pediatric MS Study Group Global Members Symposium report.

Wassmer E, Chitnis T, Pohl D, Amato MP, Banwell B, Ghezzi A, Hintzen RQ, Krupp LB, Makhani N, Rostásy K, Tardieu M, Tenembaum S, Waldman A, Waubant E, Kornberg AJ.

Neurology. 2016 Aug 30;87(9 Suppl 2):S110-6. doi: 10.1212/WNL.0000000000002880. Review.

PMID:
27572855
8.

Dystonia in a Patient with Autosomal-Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG Gene.

Rossi M, Medina Escobar A, Radrizzani M, Tenembaum S, Perandones C, Merello M.

Mov Disord Clin Pract. 2016 Jul 8;4(2):266-269. doi: 10.1002/mdc3.12397. eCollection 2017 Mar-Apr. No abstract available.

9.

Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.

Krupp LB, Pohl D, Ghezzi A, Boyko A, Tenembaum S, Chen L, Aycardi E, Banwell B; REPLAY Study Group.

J Neurol Sci. 2016 Apr 15;363:33-8. doi: 10.1016/j.jns.2016.01.023. Epub 2016 Jan 15.

10.

Update on biomarkers in neuromyelitis optica.

Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, Nakashima, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e134. doi: 10.1212/NXI.0000000000000134. eCollection 2015 Aug. Review.

11.

Comment on multiphasic disseminated encephalomyelitis followed by optic neuritis in a child with gluten sensitivity.

Tenembaum S.

Mult Scler. 2015 Aug;21(9):1212-4. doi: 10.1177/1352458515593407. Epub 2015 Jul 21. No abstract available.

PMID:
26199346
12.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International Panel for NMO Diagnosis.

Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.

13.

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT; Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K.

JAMA Neurol. 2015 Jul;72(7):815-22. doi: 10.1001/jamaneurol.2015.0248. Review.

14.

MRI characteristics of neuromyelitis optica spectrum disorder: an international update.

Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J, Banwell BL, Villoslada P, Saiz A, Fujihara K, Kim SH; Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository.

Neurology. 2015 Mar 17;84(11):1165-73. doi: 10.1212/WNL.0000000000001367. Epub 2015 Feb 18. Review.

15.

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, Tenembaum S, Banwell B, Greenberg B, Levy M, Fujihara K, Chan KH, Kim HJ, Asgari N, Sato DK, Saiz A, Wuerfel J, Zimmermann H, Green A, Villoslada P, Paul F; GJCF-ICC&BR.

Mult Scler. 2015 May;21(6):678-88. doi: 10.1177/1352458514567216. Epub 2015 Feb 6. Review.

16.

Treatment of multiple sclerosis and neuromyelitis optica in children and adolescents.

Tenembaum SN.

Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S21-9. doi: 10.1016/j.clineuro.2013.09.016. Review.

PMID:
24321150
17.

Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study.

Tenembaum SN, Banwell B, Pohl D, Krupp LB, Boyko A, Meinel M, Lehr L, Rocak S, Cantogno EV, Moraga MS, Ghezzi A; REPLAY Study Group.

J Child Neurol. 2013 Jul;28(7):849-56. doi: 10.1177/0883073813488828. Epub 2013 May 10.

PMID:
23666046
18.

Acute disseminated encephalomyelitis.

Tenembaum SN.

Handb Clin Neurol. 2013;112:1253-62. doi: 10.1016/B978-0-444-52910-7.00048-9. Review.

PMID:
23622336
19.

Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.

Van Haren K, Tomooka BH, Kidd BA, Banwell B, Bar-Or A, Chitnis T, Tenembaum SN, Pohl D, Rostasy K, Dale RC, O'Connor KC, Hafler DA, Steinman L, Robinson WH.

Mult Scler. 2013 Nov;19(13):1726-33. doi: 10.1177/1352458513485653. Epub 2013 Apr 23.

20.

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, Ghezzi A, Hintzen R, Kornberg A, Pohl D, Rostasy K, Tenembaum S, Wassmer E; International Pediatric Multiple Sclerosis Study Group.

Mult Scler. 2013 Sep;19(10):1261-7. doi: 10.1177/1352458513484547. Epub 2013 Apr 9.

PMID:
23572237
21.

International Pediatric MS Study Group Clinical Trials Summit: meeting report.

Chitnis T, Tardieu M, Amato MP, Banwell B, Bar-Or A, Ghezzi A, Kornberg A, Krupp LB, Pohl D, Rostasy K, Tenembaum S, Waubant E, Wassmer E.

Neurology. 2013 Mar 19;80(12):1161-8. doi: 10.1212/WNL.0b013e318288694e.

22.

[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].

Abad P, Nogales-Gaete J, Rivera V, Cristiano E, Hamuy F, Oehninger C, Alvarenga RM, Tenembaum S; Grupo de Estudio de Esclerosis Múltiple de Latinoamérica Lactrims.

Rev Neurol. 2012 Dec 16;55(12):737-48. Spanish.

23.

Treatment of Neuromyelitis Optica: Review and Recommendations.

Kimbrough DJ, Fujihara K, Jacob A, Lana-Peixoto MA, Leite MI, Levy M, Marignier R, Nakashima I, Palace J, de Seze J, Stuve O, Tenembaum SN, Traboulsee A, Waubant E, Weinshenker BG, Wingerchuk DM; GJCF-CC&BR.

Mult Scler Relat Disord. 2012 Oct;1(4):180-187.

24.

Ethical challenges in paediatric clinical trials in multiple sclerosis.

Tenembaum SN.

Ther Adv Neurol Disord. 2012 May;5(3):139-46. doi: 10.1177/1756285612437360.

25.

Treatment of acute disseminated encephalomyelitis.

Pohl D, Tenembaum S.

Curr Treat Options Neurol. 2012 Jun;14(3):264-75. doi: 10.1007/s11940-012-0170-0.

PMID:
22476745
26.

Multiple sclerosis in childhood and adolescence.

Tenembaum S.

J Neurol Sci. 2011 Dec;311 Suppl 1:S53-7.

PMID:
22206768
27.

Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis.

Chitnis T, Tenembaum S, Banwell B, Krupp L, Pohl D, Rostasy K, Yeh EA, Bykova O, Wassmer E, Tardieu M, Kornberg A, Ghezzi A; International Pediatric Multiple Sclerosis Study Group.

Mult Scler. 2012 Jan;18(1):116-27. doi: 10.1177/1352458511430704. Epub 2011 Dec 6.

PMID:
22146610
28.

Emerging concepts in pediatric-onset multiple sclerosis and related disorders.

Tenembaum SN.

Curr Opin Pediatr. 2010 Dec;22(6):726-30. doi: 10.1097/MOP.0b013e3283402b8a. Review.

PMID:
20885330
29.

Therapy of multiple sclerosis in children and adolescents.

Tenembaum SN.

Clin Neurol Neurosurg. 2010 Sep;112(7):633-40. doi: 10.1016/j.clineuro.2010.04.015. Epub 2010 May 14. Review.

PMID:
20471159
30.

Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.

O'Connor KC, Lopez-Amaya C, Gagne D, Lovato L, Moore-Odom NH, Kennedy J, Krupp L, Tenembaum S, Ness J, Belman A, Boyko A, Bykova O, Mah JK, Stoian CA, Waubant E, Kremenchutzky M, Ruggieri M, Bardini MR, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman MS, Iivanainen M, Bhan V, Dilenge M, Hancock MA, Gano D, Fattahie R, Kopel L, Fournier AE, Moscarello M, Banwell B, Bar-Or A.

J Neuroimmunol. 2010 Jun;223(1-2):92-9. doi: 10.1016/j.jneuroim.2010.02.019. Epub 2010 Apr 8.

PMID:
20381173
31.

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis.

McLaughlin KA, Chitnis T, Newcombe J, Franz B, Kennedy J, McArdel S, Kuhle J, Kappos L, Rostasy K, Pohl D, Gagne D, Ness JM, Tenembaum S, O'Connor KC, Viglietta V, Wong SJ, Tavakoli NP, de Seze J, Idrissova Z, Khoury SJ, Bar-Or A, Hafler DA, Banwell B, Wucherpfennig KW.

J Immunol. 2009 Sep 15;183(6):4067-76. doi: 10.4049/jimmunol.0801888. Epub 2009 Aug 17.

32.

Dystonia and tremor secondary to a pediatric thalamic stroke.

Micheli F, Cersósimo G, Palacios C, Scorticati MC, Tenembaum S, Típoli J.

Parkinsonism Relat Disord. 1998 Oct;4(3):119-22.

PMID:
18591100
33.

Disseminated encephalomyelitis in children.

Tenembaum SN.

Clin Neurol Neurosurg. 2008 Nov;110(9):928-38. doi: 10.1016/j.clineuro.2007.12.018. Epub 2008 Feb 12. Review.

PMID:
18272282
34.

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.

Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ.

Neurology. 2008 Jan 29;70(5):344-52. Epub 2007 Dec 19.

PMID:
18094334
35.

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.

Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME, Stephens D, Bar-Or A.

Lancet Neurol. 2007 Sep;6(9):773-81.

PMID:
17689148
36.

Consensus definitions proposed for pediatric multiple sclerosis and related disorders.

Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group.

Neurology. 2007 Apr 17;68(16 Suppl 2):S7-12. Review.

PMID:
17438241
37.

Treatment of pediatric multiple sclerosis and variants.

Pohl D, Waubant E, Banwell B, Chabas D, Chitnis T, Weinstock-Guttman B, Tenembaum S; International Pediatric MS Study Group.

Neurology. 2007 Apr 17;68(16 Suppl 2):S54-65. Review.

PMID:
17438239
38.

Acute disseminated encephalomyelitis.

Tenembaum S, Chitnis T, Ness J, Hahn JS; International Pediatric MS Study Group.

Neurology. 2007 Apr 17;68(16 Suppl 2):S23-36. Review.

PMID:
17438235
39.

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.

O'Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C, Robinson WH, Cherry SV, Bar-Or A, Banwell B, Fukaura H, Fukazawa T, Tenembaum S, Wong SJ, Tavakoli NP, Idrissova Z, Viglietta V, Rostasy K, Pohl D, Dale RC, Freedman M, Steinman L, Buckle GJ, Kuchroo VK, Hafler DA, Wucherpfennig KW.

Nat Med. 2007 Feb;13(2):211-7. Epub 2007 Jan 12.

40.
41.

Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis.

Tenembaum SN, Segura MJ.

Neurology. 2006 Aug 8;67(3):511-3. Epub 2006 Jun 14.

PMID:
16775230
42.

[The treatment of multiple sclerosis in Latin America: current practice and optimal standards. The findings of a survey among neurologists at an interactive workshop].

Carrá A, Rivera-Olmos V, Arcega R, Gabbai A, Haussen SR, Luetic G, San Pedro E, Tenembaum S.

Rev Neurol. 2006 Apr 1-15;42(7):399-407. Spanish.

43.

Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registry.

Bonduel M, Sciuccati G, Hepner M, Pieroni G, Torres AF, Frontroth JP, Tenembaum S.

Acta Haematol. 2006;115(3-4):180-5.

PMID:
16549893
44.

Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis.

Banwell B, Reder AT, Krupp L, Tenembaum S, Eraksoy M, Alexey B, Pohl D, Freedman M, Schelensky L, Antonijevic I.

Neurology. 2006 Feb 28;66(4):472-6.

PMID:
16505297
45.

Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients.

Tenembaum S, Chamoles N, Fejerman N.

Neurology. 2002 Oct 22;59(8):1224-31.

PMID:
12391351
46.

Prothrombotic disorders in children with moyamoya syndrome.

Bonduel M, Hepner M, Sciuccati G, Torres AF, Tenembaum S.

Stroke. 2001 Aug;32(8):1786-92.

PMID:
11486106
47.

Extratemporal epilepsy in children: candidate selection and surgical treatment.

Pomata HB, González R, Bartuluchi M, Petre CA, Ciraolo C, Caraballo R, Cersócimo R, Tenembaum S, Soprano AM, Medina CS, Rabinowicz A, Waisburg H, Taratuto AL, Monges J.

Childs Nerv Syst. 2000 Dec;16(12):842-50.

PMID:
11156299
48.

[Atypical evolutions of benign partial epilepsy of infancy with centro-temporal spikes].

Fejerman N, Caraballo R, Tenembaum SN.

Rev Neurol. 2000 Aug 16-31;31(4):389-96. Spanish.

PMID:
11008297
49.
50.

Atypical evolutions of benign localization-related epilepsies in children: are they predictable?

Fejerman N, Caraballo R, Tenembaum SN.

Epilepsia. 2000 Apr;41(4):380-90.

Supplemental Content

Loading ...
Support Center